Objectives: Stromal interacting molecule-1 (STIM1) plays a role in coordinating calcium signaling in different cell types. The increase or deletion of STIM1 expression in cardiomyocyte causes cardiac complication. Moreover, the deletion of STIM1 in endothelial cell causes vascular endothelial dysfunction. However, the disruption of STIM1 in smooth muscle cells (SMC) has no effect on endothelial function but protects vascular function when mice are infused with angiotensin-II. Nevertheless, the role of SMC-STIM1 in acute and chronic myocardial infarction (MI) induced by acute ischemia-reperfusion injury and permanent coronary artery occlusion is unknown.
Objectives: Stromal interacting molecule-1 (STIM1) plays a role in coordinating calcium signaling in different cell types. The increase or deletion of STIM1 expression in cardiomyocyte causes cardiac complication. Moreover, the deletion of STIM1 in endothelial cell causes vascular endothelial dysfunction. However, the disruption of STIM1 in smooth muscle cells (SMC) has no effect on endothelial function but protects vascular function when mice are infused with angiotensin-II. Nevertheless, the role of SMC-STIM1 in acute and chronic myocardial infarction (MI) induced by acute ischemia-reperfusion injury and permanent coronary artery occlusion is unknown.
Methods and results: Stim1
fl/fl were generated and crossed into the SM22a-Cre þ backgrounds. SM22a-Cre þ causes deletion of STIM1 floxed genes in adult SMC (Stim1 SMCÀ/À ). Control and Stim1 SMCÀ/À mice were subjected to acute ischemia-reperfusion injury. Hearts were then harvested and incubated with triphenyltetrazolium chloride to determine the infarct size. In control mice which are subjected to ischemia-reperfusion, the heart developed a significant infarct associated with an increase in STIM1 expression. Interestingly, the infarct size was substantially reduced in Stim1 SMCÀ/À mice. The protection in Stim1 SMCÀ/À mice against ischemia-reperfusion injury involves the modulation of endoplasmic reticulum stress, apoptosis, oxidative stress, protein kinase B, and mitogenactivated protein (MAP) kinase (ERK1/2 and p38) signaling, and inflammation. Furthermore, in another model of chronic MI induced by permanent coronary artery occlusion, SMC-STIM1 disruption significantly reduced myocardial infarct size and improved cardiac function.
INTRODUCTION
M yocardial infarction (MI) is the most common cause of morbidity and mortality in patients with cardiovascular complications [1] [2] [3] . Stromal interaction molecule 1(STIM1) has been shown to play a significant role in coordinating cellular calcium signaling in different cell types including SMC [4] [5] [6] [7] . STIM1 senses Ca 2þ levels changes in endoplasmic reticulum (ER) luminal [4, 5] , and directly interact with Orai channels, located at the plasma membrane, to orchestrate the opening of Ca 2þ released-activated Ca 2þ channels [8] . STIM1 is also critical in the activation of store-independent Orai1/Orai3 heteromultimeric channels [4, 5, 7, 9, 10] . STIM1 plays an essential role in vascular function and dysfunction [11] , neo-intima formation, endothelial permeability, and cardiac complications [9] [10] [11] [12] . Balloon injury of carotid arteries in rats increases the expression of STIM1, Orai1, and Orai3, which play a crucial in the development of neo-intima hyperplasia [10] . These data indicate that STIM1 and Orai channels are essential in VSMC proliferation and migration. Additionally, two elegant studies reported that the overexpression or the deletion of STIM1 specifically in cardiomyocyte cause cardiac complications [12] [13] [14] . Together, these data indicate the differential role for STIM1 cells type dependent. Previous studies showed communication through paracrine mechanism between vascular cells, stem cells, and cardiomyocyte in infarcted myocardium [15] [16] [17] . Nevertheless, the in-vivo contribution and mechanism of SMC-STIM1 in MI induced by ischemia-reperfusion injury or permanent coronary artery occlusion (PCO) is unknown.
We previously determined that ER stress is a major factor in a variety of pathologies such hypertension and diabetes [8, 18] . Indeed, the inhibition of the ER stress significantly improved vascular function in hypertension and diabetes [8, 12, 18] . Recently, it has been reported that not all ER stress pathways are detrimental. Thus, Glembotski et al. [19] reported that the ER stress transcription factor activating transcription factor 6 (ATF6) induction protects the cardiomyocytes from ischemia-reperfusion injury [20] .
The primary goal of the present study is to determine whether SMC-STIM1 plays any role in the induction of acute myocardial infarct induced by acute ischemia-reperfusion injury and chronic ischemia. We also sought to determine the mechanism by which SMC-STIM1 disruption protects the heart from acute ischemia-reperfusion injury and chronic ischemia and whether ER stress pathways, protein kinase B (Akt), and mitogen-activated protein (MAP) kinase signaling, apoptosis, and inflammation are involved. To achieve this goal, we specifically deleted STIM1 in SMC (Stim1 SMCÀ/À ) and subjected Stim1 SMCÀ/À and control mice to cardiac ischemia-reperfusion injury or PCO.
METHODS

Experimental animal and treatment
All mice experimental procedures were performed according to the American Guidelines for the Ethical Care of Animals and approved by the Institutional Animal Care and Use Committee at Eastern Virginia Medical School. STIM1 SMCÀ/À and their littermate (8-12 weeks old male) mice on the C57/Bl6 genetic background were generated by Kassan et al. [11, 21] using Stim1 flx/flx mice provided by Ma et al. [22] , NYU. Mice were divided into three groups: group 1: C57/Bl6 (C57) and groups 2 and 3: C57 and STIM1 SMCÀ/À subjected to acute cardiac ischemiareperfusion injury (24 h) or permanent coronary artery ligation for 3 weeks.
Myocardial ischemia-reperfusion injury and permanent coronary artery occlusion
We utilized mice for myocardial cardiac ischemiareperfusion injury. We anesthetized the mice with sodium pentobarbital (50 mg/kg intraperitonealy), intubated, and then ventilated using a rodent ventilator (MiniVent; Harvard Apparatus, Holliston, Massachusetts, USA). During the procedure, the body temperature of the mouse was maintained at 378C.
In one group of mice, we subjected hearts to ischemia for 30 s without any reperfusion. Then immediately we injected Evans blue into the carotid artery. This procedure is an experimental control to demonstrate that the coronary artery was ligated.
Ischemia-reperfusion injury procedures: we performed a left thoracotomy and then ligated the left anterior descending coronary artery (LAD) using 7-0 silk sutures (Ethicon Inc. St Louis, Missouri, USA) with a section of polyethylene-10 tubing placed over the LAD for 40 min. After 40-min ischemia, the LAD ligature was released, and then reperfusion was reestablished for 24 h. After 24 h of reperfusion, mice were euthanized and hearts were harvested for western blot analysis, real time PCR, and immunostaining. To determine the infarct size and area at risk (AAR), after ischemia and reperfusion for 24 h, mice were subjected to LAD religation and then injected with 1.0% of Evans blue through the carotid artery to define the in-vivo AAR. Then the heart was excised, fixed, sectioned, and stained with triphenyltetrazolium chloride (Sigma-Aldrich, T8877). Using NIH software Image J, we determined the left ventricle area, the area of risk, and the infarct size in each heart sections as previously reported [23, 24] .
Permanent coronary artery occlusion procedures: we performed a left thoracotomy, and then we ligated the LAD using 7-0 silk sutures for 3 weeks.
Echocardiography
Ejection fraction, left ventricular end diastolic dimensions (LVEDd), left ventricular end systolic dimensions (LVESd), left ventricular posterior wall thickness dimensions were measured in mice, before and 3 weeks after PCO using a Doppler echocardiograph with a 15-MHz linear transducer (Acuson c256, Mountain View, California, USA) [25] .
Collagen determination
A 6-mm heart section was cut from each slice and then stained with Masson's trichrome. We captured the whole heart images of the sections at low magnification. The ratio of scar length to the heart circumference was determined and expressed as a percentage to define collagen content using NIH software Image J. In control mice without PCO, there was very little collagen and therefore quantification was not performed.
Western blot analysis
Heart tissues were homogenized in radioimmunoprecipitation assay buffer protein extraction buffer [50 mmol/l 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, pH 7.5, 150 mmol/l NaCl, 5 mmol/l EDTA, 1% v/v nonyl phenoxypolyethoxylethanol-40, and 0.5% w/v deoxycholate], containing a cocktail of protease and phosphatase inhibitors (complete Mini; 11836153001, Roche Diagnostic). Western blot analysis for STIM1 (BD Transduction Laboratories; 610954; 1/1000; San Jose, California, USA), ER stress Biding immunoglobulin protein (BIP)/ATF6/CCAAT-enhancerbinding protein homologous protein (CHOP) (Cell Signaling Technology; 3177 and 2895; Santa Cruz Biotechnology; sc22799; 1/1000; Dallas, Texas, United States), caspase 3 (Cell Signaling Technology; 9662; 1/1000 dilution), Nox2/ Nox4 (Abcam; ab80508 and ab133303; 1/1000; Cambridge, UK), Orai2/Orai3 (Abcam; ab155216 and ab11558; 1/1000), and b-actin (Santa Cruz Biotechnology; sc47778; 1/1000) was performed as previously reported [26] .
In-situ apoptosis detection (terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling)
The presence of apoptotic cardiomyocytes within the paraffin-embedded heart sections was determined using the DAB substrate In Situ Apoptosis Detection Kit (ab206386), following the manufacturer's instructions. Data were expressed by the number of positive cells.
Apoptotic cardiomyocytes were detected by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) using a kit (TACS 2 TdT-Fluor In Situ Apoptosis Detection Kit Trevigen, Inc., Gaithersburg, Maryland, USA) as described in manufacturer's instructions. After TUNEL labeling, sections were counterstained with 4'-6-diamidino-2-phenylindole to detect nuclei.
Nicotinamide adenine dinucleotide phosphate oxidase activity assay and malondialdehyde
Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity was performed as we previously described [21] . Superoxide anion levels generated by NADPH oxidase activity were measured in lysates of hearts using lucigenin chemiluminescence. Briefly, we prepared heart lysates in a sucrose buffer [KH 2 PO 4 50 mmol/l, ethylene glycolbis(b-aminoethyl ether)-N,N,N',N'-tetraacetic acid 1 mmol/l, sucrose 150 mmol/l; pH ¼ 7.0 and the 'Complete-C mini' protease inhibitor cocktail (Roche Diagnostics, Mannheim, Germany)] in a Tissue Dounce homogenizer (PRO Scientific Inc., Oxford, Connecticut, USA) on the ice. We immediately used the aliquots of the homogenates. We used 100 ml of each lysate in a total volume of 1 ml phosphate-buffered saline buffer preheated at 37 o C, containing lucigenin (5 mmol/l) and NADPH (100 mmol/l). Blank samples contained 100 ml of sucrose buffer. We measured Lucigenin activity every 30 s for 10 min in a luminometer (Turner Biosystem 20/20, single tube luminometer) or till enzymatic activity reached a plateau. Data are expressed as percentage. NADPH oxidase activity data were normalized to protein concentration and then expressed as percentage (%) to the control.
Quantitation of reactive carbonyl compounds (malondialdehyde) was determined using the thiobarbituric acid assay as recommended by the manufacturer protocol (TCA Assay Kit, 700870) and previously described [27] .
Immunohistochemistry
Immunohistochemistry was performed as previously reported [26] . Briefly, formalin-fixed hearts were embedded in paraffin and sectioned. Slides were heated at 588C for 1 h. After removal of paraffin, endogenous peroxidase activity was quenched by 5-min incubation with 3% H 2 O 2 in H 2 O. Slides were incubated with citrate buffer (10 mmol/l, pH 6) for 10 min at 1008C and cooled to room temperature. After blocking with 5% normal goat serum, slides were incubated overnight with anti-CD68 (marker for macrophages), antimyeloperoxidase (MPO) and anti-STIM1 (cell signaling) at 48C. For every section, a negative control without the first antibody was processed. Sections were washed and incubated with biotinylated secondary antibody for 45 min, and then avidin-peroxidase conjugate (Vector Labs, Burlingame, California, USA) for 30 min at room temperature. The color reaction was developed with the diaminobenzidine detection kit (Vector Labs) and counterstained with hematoxylin. Image quantification was performed using Metamorph software.
Statistical analysis
Data are presented as mean AE standard error of the mean (SEM). The analysis was performed using GraphPad Prism6 software. Statistical calculations for significant differences were performed using Student's t-test, one way followed by post hoc test or two-way analysis of variance as appropriate. The significance level was set at probability values less than 0.05.
RESULTS
We subjected hearts to ischemia for 30 s without any reperfusion. Then immediately we injected Evans blue into the carotid artery. Heart sections above the ligation were well perfused, whereas heart sections below the suture, half of section was perfused and the other half was not perfused (Fig. 1a, b) . This procedure does not induce myocardial infarct and it is a control experiment to demonstrate that the coronary artery was completely ligated (Fig. 1a, b) .
We subjected the hearts of control and Stim1 SMCÀ/À mice to 40 min of ischemia followed by 24 h of reperfusion. The control mice subjected to cardiac ischemia-reperfusion injury displayed a significant myocardial infarct size (around 27% of the left ventricle). Interestingly, Stim1
SMCÀ/À mice subjected to cardiac ischemia-reperfusion injury displayed a significant reduction in myocardial infarct size (Fig. 1c, d, e) . The AAR was similar between the two groups of mice indicating that the ligation of the coronary was performed at the same site and therefore the hearts were subjected to comparable ischemia-reperfusion injury (Fig. 1e) . The cumulative data show a reduction in myocardial infarct size determined by the AAR, the left ventricle, and the percentage of infarct area (Fig. 1e) . Our data are supported by the recovery in sarco/endoplasmic reticulum Ca 2þ -ATPase (SERCA2A) expression (markers for myocardial infarct) in Stim1 SMCÀ/À compared to control mice subjected to the same cardiac ischemia-reperfusion injury (Fig. 1f) .
Western blot analysis revealed that STIM1 expression is augmented in the heart of control but blunted in Stim1 SMCÀ/À mice subjected to ischemia-reperfusion injury (Fig. 2a, b) . These data indicate that STIM1 in SMC dictates the expression of STIM1 in the whole heart under ischemia-reperfusion injury. The ER stress Bip and CHOP expression were enhanced, whereas ATF6 expression did not change in the heart of control mice subjected to ischemiareperfusion injury (Fig. 2a, b) . Interestingly, we observed a reduction in Bip and CHOP expression associated with an increase in ATF6 expression in heart of Stim1 SMCÀ/À mice subjected to ischemia-reperfusion injury (Fig. 2a, b) . These data suggest that the increase in Bip and CHOP are detrimental and likely involved in the induction of myocardial infarct, whereas ATF6 is protective against the myocardial infarct. The survival pathway Akt assessed with Akt phosphorylation was reduced in control, whereas intact in Stim1 SMCÀ/À subjected to ischemia-reperfusion injury (Fig. 2c, d ). MAP Kinases (ERK1/2 and p38) phosphorylation was increased in the heart of control mice subjected to ischemia-reperfusion injury but blunted in Stim1 SMCÀ/À mice (Fig. 2c, d) . The total Akt, ERK1/2, and p38 expressions were similar between all groups (Fig. 2c, d) .
The oxidative stress is an important factor in cardiovascular disease and augmented during cardiac complications [28] . Our results show an increase in NADPH oxidase activity, likely because of the enhanced Nox4 and other Nox but not Nox2 expression in control mice subjected to cardiac ischemia-reperfusion injury (Fig. 3a, b) . However, NADPH oxidase activity and Nox4 expressions were blunted in Stim1 SMCÀ/À (Fig. 3a, b) . Also, we found that malondialdehyde a product of lipid peroxidation and indicator of oxidative stress is blunted in heart of Stim1 after ischemia-reperfusion compare to control heart (Fig. 3b) . The deletion of STIM1 specifically in SMC did not affect the expression of Orai2 and Orai3 in the whole heart (Fig. 3a) .
Apoptosis is one of the mechanisms involved in the induction of myocardial infarct [29] . Our results show that caspase 3 activation (Fig. 3c, d ) and the number of TUNELpositive cells (Fig. 3e, f) were reduced in the heart from Stim1 SMCÀ/À mice compared to heart from control mice subjected to ischemia-reperfusion injury. The apoptotic cells are originated from the cardiomyocytes as indicated by fluorescent apoptotic assay (Fig. 3e) .
Inflammation is another factor involved in the induction of myocardial infarct [29] . We found an induction of inflammation as indicated by the increase in the infiltration of macrophages (CD68 staining) and neutrophils (MPO staining) into heart subjected to ischemia-reperfusion injury from control mice, which was significantly reduced in hearts subjected to ischemia-reperfusion injury from Stim1 SMCÀ/À (Fig. 4a) . Moreover, double staining revealed inflammatory cells population that coexpresses CD68 and MPO markers, and a population that does expresses CD68 or MPO (Fig. 4a) . We also confirmed that STIM1 is deleted in the Stim1 SMCÀ/À mice within SMC only (Fig. 4a) . These data are correlated with STIM1 expression (Fig. 4a) . Together, our data illustrate the essential role of SMC-STIM1 in myocardial infarct induced by acute ischemiareperfusion injury. Moreover inflammatory and cytokine markers such chemokine (C-C motif) ligand 2 (CCL2), interferon g, Interleukin-6, and tumor necrosis factor a are significantly reduced in hearts subjected to ischemia-reperfusion injury from Stim1 SMCÀ/À compared with control mice subjected to cardiac ischemia-reperfusion injury (Fig. 4b) .
We also showed the role of SMC-STIM1 in a long-term myocardial infarct. We observed that SMC-STIM1 is an important factor in heart failure induced by chronic ischemia. Thus, we found that control mice subjected to PCO developed heart failure characterized by a significant cardiac hypertrophy, myocardial infarct, drop in ejection fraction, increase in collagen content, LVEDd, and LVESd, and reduce left ventricular posterior wall thickness dimensions (Fig. 5a, b, c) . Importantly, all these factors were protected in Stim1 SMCÀ/À mice subjected to PCO (Fig. 5a, b, c) . These results indicate that cardiac function was partially protected and SMC-STIM1 plays a critical role in heart failure induced by chronic ischemia.
DISCUSSION
It has been reported that the increase or deletion of STIM1 specifically in cardiomyocytes induces cardiac complication [13, 14] . We previously reported that specific deletion of STIM1 in endothelial cells causes endothelial dysfunction, whereas specific disruption of STIM1 in SMC does not affect vascular endothelial function [11] . Moreover, we determined that SMC-STIM1 plays a crucial role in the development of hypertension and associated cardiovascular disorders. Thus, the arterial blood pressure was significantly delayed associated with vascular endothelial function protection in Stim1 SMCÀ/À mice chronically infused with angiotensin II [21] . In the present study, we identified a novel role for SMC-STIM1 as a critical factor in myocardial infarct induced by acute ischemia-reperfusion injury and chronic ischemia. Cardiac ischemia-reperfusion injury augments STIM1 expression in the whole heart and causes myocardial infarct. Importantly, the deletion of STIM1 specifically in SMC significantly reduced the myocardial infarct size through a mechanism that involves the modulation of MAP-Kinases, Akt, ER stress, oxidative stress, inflammation, and apoptosis. We also found that disruption of STIM1 in SMC protected the heart from chronic ischemia. Thus, it is likely evident that STIM1 role in physiopathology is celltype dependent that highlight the critical need to specifically target STIM1 in specific cells for potential therapy. Based on previous [21] and the present studies, we believe that SMC-STIM1 is a novel mechanism to target for cardiovascular protection.
STIM1 is a calcium sensor in the luminal side of the ER [5] . Mutations and upregulation of STIM1 expression have been associated with a variety of disorders [9, 10, 12] . We previously reported that deletion of STIM1 specifically in SMC does not affect vascular endothelial function. However, it reduces SMC contractility in response to sympathetic stimulation [11] . The significance of the present study relies on the fact that deletion of STIM1 specifically in SMC (Stim1 SMCÀ/À ) protected the heart against acute ischemiareperfusion injury and chronic ischemia. Interestingly, in Stim1 SMCÀ/À subjected to cardiac ischemia-reperfusion injury, the heart infarct size was significantly reduced compared with the infarct size in Stim1
SMCþ/þ mice subjected to ischemia-reperfusion injury. Our results are supported by the recovery in SERCA2a expression in Stim1 SMCÀ/À subjected to ischemia-reperfusion injury compared to Stim1
SMCþ/þ subjected to cardiac ischemiareperfusion injury.
ER stress is involved in a variety of metabolic and cardiovascular diseases [30, 31] . We previously showed that the inhibition of ER stress pathways improved vascular function in hypertension and diabetes [18, 32, 33] . Cardiac ischemia-reperfusion injury causes an increase in ER stress markers 'Bip and CHOP' with no change in ATF6 expression in the heart of Stim1
SMCþ/þ mice. Interestingly, Glembotski et al. reported that the ER stress ATF6 has a protective role against ischemia-reperfusion injury in isolated neonatal rat ventricular myocytes [20] . It would be interesting to selectively delete or overexpress ATF6 in SMC and delineate its role in myocardial infarct induced by ischemiareperfusion injury. The mechanisms, at the cellular level, by which STIM1 deletion specifically in SMC coordinates the ER stress activation in the whole heart and how it is related to the myocardial infarct, are yet to be elucidated. Inflammation is one the major factor involved in MI.
Previous clinical and animal studies demonstrated that there is a correlation between increase in CC chemokine ligand 2, interferon g, interleukin-6 and tumor necrosis factora levels, and MI [34] [35] [36] . These inflammatory factors are also dictated by STIM1 in SMC as indicated by their reduction in Stim1 SMCÀ/À mice subjected to ischemiareperfusion injury.
Oxidative stress, inflammation, and apoptosis are key factors in the induction of myocardial infarct [37] [38] [39] . We illustrated that the deletion of STIM1 specifically in SMC blunted the induction of oxidative stress, inflammation, and apoptosis as indicated by the reduction in the expression of Nox4, the NADPH oxidase activity, the macrophages and neutrophils infiltration, and apoptotic events. Regarding the inflammation, we observed that MPO colocalize with macrophages and some do not as previously reported [40] . The blockade of these pathways is associated with cardiac protection characterized by a significant reduction in myocardial infarct size. However, the cellular and molecular mechanism by which STIM1 in SMC orchestrates the oxidative stress, inflammation, and apoptosis under acute cardiac ischemia-reperfusion injury needs to be determined in future studies.
We utilized another model of myocardial infarct induced by cardiac chronic ischemia to determine the role of SMC-STIM1. Thus, the PCO causes heart failure in control C57/ Bl6 mice characterized by infarct induction, reduction in ejection fraction and increase in LVEDd and LVESd as previously reported [41, 42] . Interestingly, we found that FIGURE 4 (a) Representative immunolabeling of paraffin-embedded heart sections stained for macrophages (CD68-specific marker for macrophages), myeloperoxidase, and STIM1 in C57/Bl6 (C57), C57 and I/R injury, and Stim1 SMCÀ/À and I/R injury (n ¼ 4-6). The brown dark brown spots indicate immunopositive reaction to CD68, myeloperoxidase, and STIM1 antibodies. (b) Real-Time PCR for CCL2, IL-6, INFg, and TNFa. a P < 0.05 for C57 and I/R injury vs. Stim1 SMCÀ/À and I/R injury and C57 without I/R injury. CCL2, CC chemokine ligand 2; DAPI, 4'-6-diamidino-2-phenylindole;IL, interleukin; INF, interferon; I/R, ischemia-reperfusion; MPO, myeloperoxidase; SMC, smooth muscle cells; STIM1, stromal interacting molecule-1; TNF, tumor necrosis factor. these echocardiographic measurements were improved in Stim1 SMCÀ/À mice subjected to PCO. These data revealed a novel role for SMC-STIM1 in chronic MI.
In summary, the role of SMC-STIM1 as a protein that dictates the myocardial infarct induced by acute ischemiareperfusion injury and PCO is very complex. STIM1 has been shown to play a differential role cells type dependent. The present study highlights the in-vivo contribution and provides proof-of-concept that disruption of SMC-STIM1 protects the heart against acute ischemia-reperfusion injury through mechanisms that involves reduction of ERK1/2, oxidative stress, ER stress, apoptosis, and inflammation. We also provided evidence that SMC-STIM1 disruption protects the heart against chronic myocardial infarct and heart failure induced by PCO. Therefore, the present study opens new avenues for exploring the cellular interaction and molecular mechanisms by which STIM1 in SMC govern the events of myocardial infarct. Also SMC-STIM1 is a potential target to protect patients with heart complications.
Perspectives and limitation
We previously reported that STIM1 plays differential roles cell-type dependent. Thus, we found that deletion of STIM1 in endothelial cells cause vascular endothelial dysfunction. However, the deletion of STIM1 in SMC does not affect vascular endothelial function but reduced vascular contractility in response to phenylephrine [11] . Our recent publication indicated that disruption of STIM1 in SMC protected the cardiovascular system in mouse chronically infused with angiotensin II [21] . Moreover, it has been reported that deletion or overexpression of STIM1 in cardiomyocytes compromises cardiac structure and function [13, 14] . In the present study, we determined that STIM1 in SMC is critical in myocardial infarct induced by acute cardiac ischemiareperfusion injury or chronic cardiac ischemia. Thus, based on our results, we believe that developing a specific inhibitor or local gene therapy that target STIM1 in SMC will benefit patients with cardiovascular complications.
The present manuscript has limitations. First, we do not know how SMCs receive signals in response to acute ischemia-reperfusion injury or chronic ischemia. Second, what are the factors dictated by STIM1 in SMC? Third, what are the factors released by SMC Stim1À/À that protect the heart against ischemia-reperfusion injury and chronic ischemia. These questions are important, as it will help understanding the mechanism of how VSMCs are important in MI.
Novelty and significance
What is known? Stromal Interacting Molecule 1 (STIM1) is known to play an important role in coordinating cellular calcium signaling in a variety of cells. STIM1 senses changes in endoplasmic reticulum luminal calcium levels and directly interact with Orai channels located at the plasma membrane to orchestrate the opening of calcium released-activated calcium channels (CRAC). STIM1 plays a critical role in vascular function, vascular complications, and cardiac hypertrophy. However, the role of SMC STIM1 in myocardial infarction is still unknown.
What is new?
Utilizing a new mouse model in which STIM1 was specifically deleted in SMCs, the results indicate that SMC-STIM1 plays a critical role in the myocardial infarct induced by acute I/R injury and chronic coronary occlusion. The deletion of SMC-STIM1 protects the heart from the adverse effect of acute I/R injury and heart failure. This article also highlights that the cardioprotection of SMC-STIM1 deletion involves the modulation of the endoplasmic reticulum stress, oxidative stress, MAP Kinases, apoptosis and inflammation-dependent mechanism. Overall, these studies identified new role for SMC-STIM1 in myocardial infarction.
